▲ +12.95% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for U.S. Physical Therapy in the last 3 months. The average price target is $132.50, with a high forecast of $135.00 and a low forecast of $130.00. The average price target represents a 12.95% upside from the last price of $117.31.
The current consensus among 2 investment analysts is to buy stock in U.S. Physical Therapy. This rating has held steady since March 2021, when it changed from a Hold consensus rating.
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2020, it operated 544 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities. The company was founded in 1990 and is based in Houston, Texas.